Introduction to Chronic Graft-vs-Host Disease (GVHD) 2018

(53:51)

Chronic Graft-vs-Host Disease (GVHD) of Skin and Connective Tissues 2018

(50:13)

Introduction to Chronic Graft-versus-Host Disease 2019

(58:25)

Chronic Graft-versus-Host Disease of the Skin and Connective Tissue 2022

(58:7)

Introduction to Chronic Graft versus Host Disease 2020

(59:50)

Case 3: Moderate Chronic Graft-Versus-Host Disease

(2:28)

Introduction to Chronic Graft versus Host Disease 2016

(1:28)

Chronic Graft-vs-Host Disease (GVHD) of the Gastrointestinal Tract and Liver 2018

(59:14)

Introduction to Chronic Graft versus Host Disease 2017

(47:45)

Case 3: Treating Chronic Graft-Versus-Host Disease

(3:35)

David Miklos, MD, PhD: Ibrutinib in Chronic Graft-Versus-Host Disease

(9:28)

Chronic Graft versus Host Disease of Skin and Connective Tissues 2016

(56:28)

Chronic Graft-versus-Host Disease of the Skin and Connective Tissues 2021

(58:29)

Chronic Graft-versus-Host Disease of Skin and Connective Tissues 2020

(59:21)

Chronic Graft-Vs.-Host Disease (GvHD) | 2022 BMT Reunion Workshops

(22:45)

Updates in Chronic Graft-versus-Host Disease (GVHD) Management

(22:19)

Graft-Versus-Host Disease by C. Duncan | OPENPediatrics

(42:31)

Ruxolitinib Appears Promising as Treatment of Chronic Graft-Versus-Host Disease

(1:6)

Your Eyes and Chronic Graft vs Host Disease 2019

(56:5)

Your Mouth and Chronic Graft-versus-Host Disease 2022

(1:6:37)